Literature DB >> 27895133

Vancomycin and the Risk of AKI: Now Clearer than Mississippi Mud.

Thomas D Nolin1,2.   

Abstract

Entities:  

Keywords:  Acute Kidney Injury; Mississippi; Risk; Vancomycin; acute renal failure; drug nephrotoxicity; nephrotoxicity; vancomycin

Mesh：

Substances：

Year:  2016        PMID： 27895133      PMCID： PMC5142077          DOI： 10.2215/CJN.11011016

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  17 in total

Review 1.  Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

Authors:  Sepideh Elyasi; Hossein Khalili; Simin Dashti-Khavidaki; Amirhooshang Mohammadpour
Journal:  Eur J Clin Pharmacol       Date:  2012-03-13       Impact factor: 2.953

2.  The costs of adverse drug events in community hospitals.

Authors:  Balthasar L Hug; Carol Keohane; Diane L Seger; Catherine Yoon; David W Bates
Journal:  Jt Comm J Qual Patient Saf       Date:  2012-03

3.  Factors associated with vancomycin nephrotoxicity in the critically ill.

Authors:  T P Hanrahan; C Kotapati; M J Roberts; J Rowland; J Lipman; J A Roberts; A Udy
Journal:  Anaesth Intensive Care       Date:  2015-09       Impact factor: 1.669

Review 4.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael Rybak; Ben Lomaestro; John C Rotschafer; Robert Moellering; William Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Am J Health Syst Pharm       Date:  2009-01-01       Impact factor: 2.637

Review 5.  Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis.

Authors:  Abhisekh Sinha Ray; Ammar Haikal; Kassem A Hammoud; Alan S L Yu
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-28       Impact factor: 8.237

6.  Nephrotoxicity of vancomycin, alone and with an aminoglycoside.

Authors:  M J Rybak; L M Albrecht; S C Boike; P H Chandrasekar
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

7.  Studies of risk factors for aminoglycoside nephrotoxicity.

Authors:  C R Smith; R D Moore; P S Lietman
Journal:  Am J Kidney Dis       Date:  1986-11       Impact factor: 8.860

8.  Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.

Authors:  Timothy P Hanrahan; Georgina Harlow; James Hutchinson; Joel M Dulhunty; Jeffrey Lipman; Tony Whitehouse; Jason A Roberts
Journal:  Crit Care Med       Date:  2014-12       Impact factor: 7.598

9.  Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.

Authors:  Thomas P Lodise; Ben Lomaestro; Jeffrey Graves; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

10.  Phenotype standardization for drug-induced kidney disease.

Authors:  Ravindra L Mehta; Linda Awdishu; Andrew Davenport; Patrick T Murray; Etienne Macedo; Jorge Cerda; Raj Chakaravarthi; Arthur L Holden; Stuart L Goldstein
Journal:  Kidney Int       Date:  2015-04-08       Impact factor: 10.612
View more
  4 in total

1.  Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: COMMENTARY.

Authors:  Mark A Perazella
Journal:  Kidney360       Date:  2022-01-26

Review 2.  Piperacillin-Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?

Authors:  Abdullah Tarık Aslan; Murat Akova
Journal:  Healthcare (Basel)       Date:  2022-08-20

3.  Renoprotective Effects of Melatonin against Vancomycin-Related Acute Kidney Injury in Hospitalized Patients: a Retrospective Cohort Study.

Authors:  Thomas S Hong; Kelsey Briscese; Marshall Yuan; Kiran Deshpande; Lauren M Aleksunes; Luigi Brunetti
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

4.  Vancomycin associated acute kidney injury in pediatric patients.

Authors:  Brady S Moffett; Jennifer Morris; Charissa Kam; Marianne Galati; Ankhi Dutta; Ayse Akcan-Arikan
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.